FH25: Exploring the intersection of patients, HCPs, and technology with Denise Silber
Newsletters and Deep Dive digital magazine
Whole-genome sequencing provides an unbiased and complete view of the human genome and enables the discovery of genetic variation.
At Frontiers Health 2025, Mike Ryan, General Manager Europe at EVERSANA, tackled one of the most pressing questions for emerging pharma and biotech...
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
Every breakthrough in medicine, every new treatment that changes lives, starts with research.
In a new white paper from Lumanity, explore why the most powerful AI will always be human-directed.
Cary Claiborne, CEO of Adial Pharmaceuticals, discusses his company’s bet on a precision treatment for AUD.
A new industry report uncovers the scope of a long-ignored problem in clinical trial operations.
Amiculum, a global health communications agency, has entered into an exciting strategic collaboration with VuuAI, a GenAI-driven content production automation plat
The Summit is the leading European industry-focused forum dedicated to accelerating the development of messenger RNA (mRNA) medicines
Get in-depth news, opinions, and features on pharma and healthcare sent straight to your inbox